Additionally, we found a significant association (p=0.0044, Chi-square test) between the MYD88 L265P and CD79B Y196 mutations, suggesting collaborative effects of the NFκB activating pathways in PCNSL. The gene discussed is NFKB1; the disease is primary central nervous system lymphoma.